Potential toxic effects of TDCIPP on the thyroid in female SD rats.
10.12047/j.cjap.5979.2020.055
- Author:
Jing Ran SUN
1
;
Mi Mi FAN
1
;
Zhen ZHANG
2
;
Jin WU
1
;
Dian Peng HAN
1
;
Jia Lei BAI
1
;
Lian Qun DU
1
;
Yan Jun FANG
1
Author Information
1. Institute of Environmental and Operational Medicine, Academy of Military Medical Science, Tianjin 300050.
2. Materials Science, North University of China, Taiyuan 030051, China.
- Publication Type:Journal Article
- Keywords:
TDCIPP;
mouse;
thyroid;
thyroid hormone;
toxic effect
- From:
Chinese Journal of Applied Physiology
2020;36(3):250-254
- CountryChina
- Language:Chinese
-
Abstract:
To investigate the potential toxic effects and mechanisms of Tris(1; 3-dichloro-2-propyl) phosphate (TDCIPP) on thyroid in female SD rats. Thirty-two 3-weeks-old female SD rats were randomly divided into normal group(treated with corn oil ), and low/moderate/high-dose group treated with TDCIPP (dissolved in corn oil )(n=8). All rats were treated with corn oil or TDCIPP (50, 100, 250 mg/(kg·d)) once a day during a 21-day period. All rats were sacrificed after the last administration. Serum thyroid stimulating hormone (TSH), 3,3',5-triiodothyronine (T3), 3,3',5,5'-tetraiodothyronine (T4), free 3,3',5,5'-tetraiodothyronine (FT4) were detected with ELISA kit. Morphology of thyroid was observed with hematoxylin and eosin (HE) staining. Expressions of genes and proteins correlate with thyroid were measured respectively by real-time fluorescence quantitative PCR and Western blot. Compared with control group, morphology of thyroid showed follicles irregular arrangement, hypocolloid, and follicular hyperplasia in TDCIPP treatment groups. The levels of serum TSH in low-dose TDCIPP group and T3 in high-dose TDCIPP group were significantly higher than those in control group(P＜0.05). Thyroid stimulating hormone receptor (TSHR) mRNA expression was decreased distinctly in low-dose TDCIPP group, while the expression of thyroperoxidase (TPO) mRNA was increased notably in moderate and high-dose TDCIPP groups(P＜0.05,P＜0.01). Compared with control group, the level of TRβ protein was decreased significantly in moderate and high-dose TDCIPP groups, while the expressions of udp-glucuronosyl-transferases (UGTs) and cytochrome-p450-3A1 (CYP3A1) proteins were upregulated notably in TDCIPP treatment groups(P＜0.05). Treated with 50 mg/(kg·d) TDCIPP can cause thyroid hyperplasia, change the levels of thyroid hormones, and disturb thyroid function, therefore, it has toxic effects on the thyroid.
